Page last updated: 2024-11-12
phyllomedusin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 10441328 |
| MeSH ID | M0131861 |
Synonyms (4)
| Synonym |
|---|
| phyllomedusin |
| HY-P3092 |
| CS-0144792 |
| DTXSID101043460 |
Research Excerpts
Overview
Phyllomedusinae is a formidable factory and store-house of a variety of active peptides belonging to seven families. The caeruleins, bradykinins, bombesins, sauvagine, dermorphins and tryptophyllins are among the members.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Phyllomedusinae is a formidable factory and store-house of a variety of active peptides belonging to seven distinct families: the caeruleins (represented by phyllocaerulein), the bradykinins (phyllokinin), the tachykinins (phyllomedusin), the bombesins (phyllolitorin, [Leu8]phyllolitorin, rohdei-litorin), sauvagine, the dermorphins (dermorphin, [Hyp6]dermorphin) and finally the tryptophyllins (a set of 8-11 members)." | ( Phyllomedusa skin: a huge factory and store-house of a variety of active peptides. de Castiglione, R; Erspamer, V; Falconieri Erspamer, G; Melchiorri, P; Montecucchi, PC, 1985) | 0.99 |
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " The order of potency, the maximal effect and the slope of the dose-response curve were examined with six tachykinins - substance P (SP), physalaemin, phyllomedusin, uperolein, eledoisin, kassinin - and several substance P fragments - SP-(2-11), SP-(3-11), SP-(4-11) and SP-(6-11)." | ( Interaction of tachykinins with an adrenergic receptor in the rat urinary bladder. Mathison, R; Solomos, D, 1985) | 0.47 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 19.97
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.97) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||